Preclinical and clinical activity of DZD1516, a full blood-brain barrier-penetrant, highly selective HER2 inhibitor
Zhang, Jian, McAndrew, Nicholas P, Wang, Xiaojia, Du, Yiqun, DiCarlo, Brian, Wang, Mei, Chen, Kan, Yu, Wenlei, Hu, Xichun
Published in Breast cancer research : BCR (06.07.2023)
Published in Breast cancer research : BCR (06.07.2023)
Get full text
Journal Article
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
Hurvitz, Sara A, Caswell-Jin, Jennifer L, McNamara, Katherine L, Zoeller, Jason J, Bean, Gregory R, Dichmann, Robert, Perez, Alejandra, Patel, Ravindranath, Zehngebot, Lee, Allen, Heather, Bosserman, Linda, DiCarlo, Brian, Kennedy, April, Giuliano, Armando, Calfa, Carmen, Molthrop, David, Mani, Aruna, Chen, Hsiao-Wang, Dering, Judy, Adams, Brad, Kotler, Eran, Press, Michael F, Brugge, Joan S, Curtis, Christina, Slamon, Dennis J
Published in Nature communications (17.11.2020)
Published in Nature communications (17.11.2020)
Get full text
Journal Article
Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
Noor, Zorawar S., Goldman, Jonathan W., Lawler, William E., Telivala, Bijoy, Braiteh, Fadi, DiCarlo, Brian A., Kennedy, Kathleen, Adams, Brad, Wang, Xiaoyan, Jones, Benjamin, Slamon, Dennis J., Garon, Edward B.
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2019)
Published in Lung cancer (Amsterdam, Netherlands) (01.09.2019)
Get full text
Journal Article
Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09)
Hurvitz, Sara, Singh, Rashi, Adams, Brad, Taguchi, Julie A., Chan, David, Dichmann, Robert A., Castrellon, Aurelio, Hu, Eddie, Berkowitz, Jonathan, Mani, Aruna, DiCarlo, Brian, Callahan, Rena, Smalberg, Ira, Wang, Xiaoyan, Meglar, Ivana, Martinez, Diego, Hobbs, Evthokia, Slamon, Dennis J.
Published in Therapeutic advances in medical oncology (01.01.2018)
Published in Therapeutic advances in medical oncology (01.01.2018)
Get full text
Journal Article
UCLA l-08: A phase ib/II study of combined HER inhibition adding necitumumab and trastuzumab to osimertinib in patients with refractory EGFR-mutated lung cancer
Goldman, Jonathan W., Cummings, Amy Lauren, Arzoo, Karo K., Hu, Eddie Hong-Lung, Garon, Edward B., Kirimis, Evangelia K., Olevsky, Olga, DiCarlo, Brian Anthony, Davidson, Sheldon J., Kaul, Anita, Noor, Zorawar Singh, Mendenhall, Melody A., Wong, Deborah J.L., Huang, Holly K.T., Velez, Maria A, Chauv, James, Yarden, Yosef, Slamon, Dennis J.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
TRIO-US B-12 TALENT: Phase II neoadjuvant trial evaluating trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early-stage breast cancer
Hurvitz, Sara A., Wang, Lisa S., Chan, David, Phan, Vu, Lomis, Thomas, McAndrew, Nicholas Patrick, Spring, Laura, Tetef, Merry L., Villa, Deborah, Applebaum, Steven, Chamberlain, Erin, Dakhil, Shaker R., DiCarlo, Brian Anthony, Kim, David D., Kirimis, Evangelia K., Lawler, William E., Master, Aashini K., Kivork, Christine, Chauv, James, Bardia, Aditya
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Final Results and Biomarker Correlation of a Phase II Study of the MTOR Inhibitor Everolimus in Patients with Pre-Treated Metastatic Esophagus, Gastro-Esophageal Junction and Gastric Adenocarcinoma
Zev, Wainberg, Ravi, Patel, David, Park, Andre, Liem, Lisa, Yonemoto, Brian, DiCarlo, He-Jing, Wang, Diego, Martinez, Hecht, J.
Published in Annals of oncology (01.06.2014)
Published in Annals of oncology (01.06.2014)
Get full text
Journal Article
Abstract GS2-03: GS2-03 TRIO-US B-12 TALENT: Neoadjuvant trastuzumab deruxtecan with or without anastrozole for HER2-low, HR+ early stage breast cancer
Bardia, Aditya, Hurvitz, Sara, Press, Michael F., Wang, Lisa S., McAndrew, Nicholas P., Chan, David, Phan, Vu, Villa, Deborah, Tetef, Merry L., Chamberlain, Erin, Abdulla, Nihal, Lomis, Thomas, Spring, Laura M., Applebaum, Steven, Dakhil, Shaker, DiCarlo, Brian, Kim, David D., Kirimis, Evangelia, Lawler, William E., Master, Aashini K., McCann, Kelly, Hayashi, Edwin, Kivork, Christine, Chauv, James
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers
Wainberg, Zev A., Soares, Heloisa P., Patel, Ravi, DiCarlo, Brian, Park, David J., Liem, Andre, Wang, He-jing, Yonemoto, Lisa, Martinez, Diego, Laux, Isett, Brennan, Meghan, Hecht, J. Randolph
Published in Cancer chemotherapy and pharmacology (01.07.2015)
Published in Cancer chemotherapy and pharmacology (01.07.2015)
Get full text
Journal Article
An open-label phase II clinical trial of the RXR agonist IRX4204 in taxane-resistant, castration-resistant metastatic prostate cancer (CRPC)
Kabbinavar, Fairooz F., Zomorodian, Nazy, Rettig, Matthew, Khan, Faraz, Greenwald, Daniel Reif, Davidson, Sheldon J., DiCarlo, Brian Anthony, Patel, Ravi, Pandit, Lalita, Chandraratna, Rosh, Sanders, Martin
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A phase 1b, open-label, non-randomized multicenter study of birinapant in combination with conatumumab in subjects with relapsed epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer
Hamilton, Erika Paige, Birrer, Michael J., DiCarlo, Brian Anthony, Gaillard, Stephanie, Martin, Lainie P., Nemunaitis, John J., Perez, Raymond P., Schilder, Russell J., Annunziata, Christina M., Begley, Colin G., Hager, Steven Jeffrey
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
An open-label phase II clinical trial of the RXR agonist IRX4204 in taxane-resistant, castration-resistant metastatic prostate cancer (CRPC)
Kabbinavar, Fairooz F., Zomorodian, Nazy, Rettig, Matthew, Khan, Faraz, Greenwald, Daniel Reif, DiCarlo, Brian, Davidson, Sheldon J., Patel, Ravindranath, Pandit, Lalita, Chandraratna, Rosh, Sanders, Martin
Published in Journal of clinical oncology (01.02.2014)
Published in Journal of clinical oncology (01.02.2014)
Get full text
Journal Article
Interim results of a phase II study of the mTOR inhibitor everolimus in patients with pretreated metastatic gastric and esophageal adenocarcinoma
Wainberg, Zev A., Patel, Ravi, DiCarlo, Brian, Park, David J, Kass, Frederic C., Liem, Andre K. D., Wang, He-jing, Martinez, Diego, Hecht, J. Randolph
Published in Journal of clinical oncology (01.02.2012)
Published in Journal of clinical oncology (01.02.2012)
Get full text
Journal Article
ILLUMINATION SYSTEM ADAPTED FOR SURGICAL LIGHTING
BOULANT, BENOIT, DICARLO, BRIAN, JAMES, BRUKILACCHIO, THOMAS, J, MAYSHACK, ALVIN, C, NOBLE, LYNN, W, ELTERMAN, PAUL, B, PIEVSKY, ARKADY
Year of Publication 09.10.2002
Get full text
Year of Publication 09.10.2002
Patent
ILLUMINATION SYSTEM ADAPTED FOR SURGICAL LIGHTING
BOULANT, BENOIT, DICARLO, BRIAN, JAMES, BRUKILACCHIO, THOMAS, J, MAYSHACK, ALVIN, C, NOBLE, LYNN, W, ELTERMAN, PAUL, B, PIEVSKY, ARKADY
Year of Publication 31.10.2001
Get full text
Year of Publication 31.10.2001
Patent
ILLUMINATION SYSTEM ADAPTED FOR SURGICAL LIGHTING
BOULANT, BENOIT, DICARLO, BRIAN, JAMES, BRUKILACCHIO, THOMAS, J, MAYSHACK, ALVIN, C, NOBLE, LYNN, W, ELTERMAN, PAUL, B, PIEVSKY, ARKADY
Year of Publication 22.06.2000
Get full text
Year of Publication 22.06.2000
Patent